{
 "source": [
  "https://open.fda.gov/apis/drug/drugsfda/",
  "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks"
 ],
 "snapshot": "2026-10-19T16:52:02.924Z",
 "compoundingPageCurrentAsOf": "04/22/2026",
 "rows": [
  {
   "compound": "Afamelanotide",
   "url": "https://residue.info/c/afamelanotide/",
   "evidenceGrade": "A",
   "fdaApproval": "Approved",
   "applications": [
    {
     "app": "NDA210797",
     "brands": [
      "SCENESSE"
     ],
     "sponsor": "CLIVUNEL INC",
     "first": "2019-10-08",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210797"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Bremelanotide",
   "url": "https://residue.info/c/bremelanotide/",
   "evidenceGrade": "A",
   "fdaApproval": "Approved",
   "applications": [
    {
     "app": "NDA210557",
     "brands": [
      "VYLEESI (AUTOINJECTOR)"
     ],
     "sponsor": "COSETTE",
     "first": "2019-06-21",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Elamipretide",
   "url": "https://residue.info/c/elamipretide/",
   "evidenceGrade": "A",
   "fdaApproval": "Approved",
   "applications": [
    {
     "app": "NDA215244",
     "brands": [
      "FORZINITY"
     ],
     "sponsor": "STEALTH BIOTHERAPS",
     "first": "2025-09-19",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215244"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Semaglutide",
   "url": "https://residue.info/c/semaglutide/",
   "evidenceGrade": "A",
   "fdaApproval": "Approved",
   "applications": [
    {
     "app": "NDA215256",
     "brands": [
      "WEGOVY",
      "WEGOVY HD",
      "WEGOVY FLEXTOUCH"
     ],
     "sponsor": "NOVO",
     "first": "2021-06-04",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256"
    },
    {
     "app": "NDA218316",
     "brands": [
      "WEGOVY"
     ],
     "sponsor": "NOVO",
     "first": "2025-12-22",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218316"
    },
    {
     "app": "NDA213051",
     "brands": [
      "OZEMPIC",
      "RYBELSUS"
     ],
     "sponsor": "NOVO",
     "first": "2019-09-20",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051"
    },
    {
     "app": "NDA209637",
     "brands": [
      "OZEMPIC"
     ],
     "sponsor": "NOVO",
     "first": "2017-12-05",
     "status": "Prescription, Discontinued",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637"
    },
    {
     "app": "NDA213182",
     "brands": [
      "RYBELSUS"
     ],
     "sponsor": "NOVO NORDISK INC",
     "first": "2020-01-16",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213182"
    },
    {
     "app": "ANDA220314",
     "brands": [
      "SEMAGLUTIDE"
     ],
     "sponsor": "APOTEX INC",
     "first": "2026-04-07",
     "status": "None (Tentative Approval)",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220314"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Tesamorelin",
   "url": "https://residue.info/c/tesamorelin/",
   "evidenceGrade": "A",
   "fdaApproval": "Approved",
   "applications": [
    {
     "app": "BLA022505",
     "brands": [
      "EGRIFTA"
     ],
     "sponsor": "THERATECHNOLOGIES",
     "first": "2010-11-10",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022505"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Tirzepatide",
   "url": "https://residue.info/c/tirzepatide/",
   "evidenceGrade": "A",
   "fdaApproval": "Approved",
   "applications": [
    {
     "app": "NDA217806",
     "brands": [
      "ZEPBOUND",
      "ZEPBOUND KWIKPEN",
      "ZEPBOUND (AUTOINJECTOR)"
     ],
     "sponsor": "ELI LILLY AND CO",
     "first": "2023-11-08",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806"
    },
    {
     "app": "NDA215866",
     "brands": [
      "MOUNJARO",
      "MOUNJARO KWIKPEN",
      "MOUNJARO (AUTOINJECTOR)"
     ],
     "sponsor": "ELI LILLY AND CO",
     "first": "2022-05-13",
     "status": "Prescription",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215866"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Sermorelin",
   "url": "https://residue.info/c/sermorelin/",
   "evidenceGrade": "A",
   "fdaApproval": "Discontinued",
   "applications": [
    {
     "app": "NDA019863",
     "brands": [
      "GEREF"
     ],
     "sponsor": "EMD SERONO",
     "first": "1990-12-28",
     "status": "Discontinued",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019863"
    },
    {
     "app": "NDA020443",
     "brands": [
      "GEREF"
     ],
     "sponsor": "EMD SERONO INC",
     "first": "1997-09-26",
     "status": "Discontinued",
     "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020443"
    }
   ],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "AOD-9604",
   "url": "https://residue.info/c/aod-9604/",
   "evidenceGrade": "D",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "BPC-157",
   "url": "https://residue.info/c/bpc-157/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Cagrilintide",
   "url": "https://residue.info/c/cagrilintide/",
   "evidenceGrade": "B",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "CJC-1295",
   "url": "https://residue.info/c/cjc-1295/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "DSIP",
   "url": "https://residue.info/c/dsip/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Epitalon",
   "url": "https://residue.info/c/epitalon/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "GHK-Cu",
   "url": "https://residue.info/c/ghk-cu/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Ipamorelin",
   "url": "https://residue.info/c/ipamorelin/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Category 2 (503B)"
  },
  {
   "compound": "Kisspeptin-10",
   "url": "https://residue.info/c/kisspeptin-10/",
   "evidenceGrade": "B",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Category 2 (503A)"
  },
  {
   "compound": "KPV",
   "url": "https://residue.info/c/kpv/",
   "evidenceGrade": "D",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "LL-37",
   "url": "https://residue.info/c/ll-37/",
   "evidenceGrade": "B",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Melanotan II",
   "url": "https://residue.info/c/melanotan-ii/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "MOTS-c",
   "url": "https://residue.info/c/mots-c/",
   "evidenceGrade": "D",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Retatrutide",
   "url": "https://residue.info/c/retatrutide/",
   "evidenceGrade": "B",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Not on FDA list"
  },
  {
   "compound": "Selank",
   "url": "https://residue.info/c/selank/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Semax",
   "url": "https://residue.info/c/semax/",
   "evidenceGrade": "C",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "TB-500",
   "url": "https://residue.info/c/tb-500/",
   "evidenceGrade": "D",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  },
  {
   "compound": "Thymosin alpha-1",
   "url": "https://residue.info/c/thymosin-alpha-1/",
   "evidenceGrade": "B",
   "fdaApproval": "None",
   "applications": [],
   "compounding": "Nomination withdrawn; risks listed"
  }
 ]
}